Tag: innovation

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- Purpose Investments Inc. (“Purpose Investments”) announced today its decision to terminate StoneCastle Equity Growth Fund and StoneCastle Income Growth Fund (each, a “StoneCastle Fund” and together, the “StoneCastle Funds”) at the close of business on or about September 29, 2025 (the “StoneCastle Funds’ Termination Date”). Effective immediately, each StoneCastle Fund is closed to new purchases. Purpose Investments also announced its decision to terminate PK Core Fund effective as of the close of business today. PK Core Fund currently has no unitholders and is closed to new purchases.

TORONTO, 25 juill. 2025 (GLOBE NEWSWIRE) -- Investissements Purpose Inc. (« Investissements Purpose ») a annoncé aujourd’hui sa décision de dissoudre le Fonds de croissance des actions StoneCastle et le Fonds de croissance du revenu StoneCastle (chacun, un « Fonds StoneCastle » et, ensemble, les « Fonds StoneCastle ») à la fermeture des bureaux le 29 septembre 2025 ou vers cette date (la « date de dissolution des Fonds StoneCastle »). Dès maintenant, chaque Fonds StoneCastle est fermé aux nouvelles souscriptions. Investissements Purpose a également annoncé sa décision de dissoudre le Fonds de base PK à compter de la fermeture des bureaux aujourd’hui. Le Fonds de base PK n’a actuellement aucun porteur de parts et est fermé aux nouveaux achats.

SOUTH SAN FRANCISCO, July 25, 2025 (GLOBE NEWSWIRE) -- Recognify Life Sciences, a clinical-stage biotech company focused on developing treatments for cognitive impairment, today announced that its randomized, double-blind, placebo-controlled Phase 2b clinical trial evaluating inidascamine (formerly RL-007) in patients with cognitive impairment associated with schizophrenia (CIAS) did not meet its primary endpoint.

Global medical cannabis market to hit USD 68.6 billion by 2033, growing at a 7.1% CAGR. Key growth drivers include increasing legalization and therapeutic use for conditions like chronic pain and epilepsy. North America leads due to progressive regulations. Top players like Canopy Growth and GW Pharmaceuticals drive innovation in the sector.